Similar articles

• Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine.

  Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K. Nakano S, et al. J Nucl Med. 1989 Mar;30(3):337-42. J Nucl Med. 1989. PMID: 2786938
• [Regional cerebral blood flow measurement using N-isopropyl-p-[123I] iodoamphetamine and rotating gamma camera emission computed tomography].

  Matsuda H, Seki H, Ishida H, Sumiya H, Tsuji S, Hisada K, Fujii H, Yamamoto S, Kobayashi H, Hayashi M. Matsuda H, et al. Kaku Igaku. 1985 Jan;22(1):9-18. Kaku Igaku. 1985. PMID: 3873559 Japanese. No abstract available.
• [Crossed cerebellar diaschisis in cerebrovascular disease detected by N-isopropyl I-123 p-iodoamphetamine (I-123 IMP) with SPECT].

  Momose T, Kosaka N, Nishikawa J, Machida K, Ohtake T, Tsuchiya K, Machida T, Watanabe E, Iio M. Momose T, et al. Kaku Igaku. 1986 Jan;23(1):25-34. Kaku Igaku. 1986. PMID: 3486304 Japanese. No abstract available.
• [123I]iodoamphetamine SPECT imaging.

  Cohen MB, Graham LS, Yamada LS. Cohen MB, et al. Int J Rad Appl Instrum A. 1986;37(8):749-63. doi: 10.1016/0883-2889(86)90270-4. Int J Rad Appl Instrum A. 1986. PMID: 3021677 Review.
• Clinical brain imaging with isopropyl-iodoamphetamine and SPECT.

  Royal HD, Hill TC, Holman BL. Royal HD, et al. Semin Nucl Med. 1985 Oct;15(4):357-76. doi: 10.1016/s0001-2998(85)80014-3. Semin Nucl Med. 1985. PMID: 3904005 Review.